End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
Jul. 08 | Tonix Pharmaceuticals Intends to Offer and Sell Shares of its Common Stock | CI |
Jul. 08 | Tonix Pharmaceuticals Plans Stock Offering; Shares Fall After-Hours | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,832,587 | 9,536,923 ( 96.99 %) | 0 | 96.99 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.com![address Tonix Pharmaceuticals(TNXP)](https://cdn.zonebourse.com/static/address/47362663.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 96.32B | |
+4.21% | 40.77B | |
-11.86% | 33.21B | |
+81.50% | 29.36B | |
-14.25% | 15.7B | |
-7.36% | 13.08B | |
-13.08% | 11.39B | |
+176.65% | 10.47B | |
-57.36% | 8.58B |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock
- Company Tonix Pharmaceuticals